The Evolving Protein Engineering in the Design of Chimeric Antigen Receptor T Cells

por Hughes-Parry, Hannah E., Cross, Ryan S., Jenkins, Misty R.
Publicado 2019

To go or not to go? Biological logic gating engineered T cells

por Abbott, Rebecca C, Hughes-Parry, Hannah E, Jenkins, Misty R
Publicado 2022

Human EGFRvIII chimeric antigen receptor T cells demonstrate favorable safety profile and curative responses in orthotopic glioblastoma

por Abbott, Rebecca C, Iliopoulos, Melinda, Watson, Katherine A, Arcucci, Valeria, Go, Margareta, Hughes‐Parry, Hannah E, Smith, Pete, Call, Melissa J, Cross, Ryan S, Jenkins, Misty R
Publicado 2023

HER2 chimeric antigen receptor T cell immunotherapy is an effective treatment for diffuse intrinsic pontine glioma

por Wang, Stacie S, Davenport, Alexander J, Iliopoulos, Melinda, Hughes-Parry, Hannah E, Watson, Katherine A, Arcucci, Valeria, Mulazzani, Matthias, Eisenstat, David D, Hansford, Jordan R, Cross, Ryan S, Jenkins, Misty R
Publicado 2023

Novel high‐affinity EGFRvIII‐specific chimeric antigen receptor T cells effectively eliminate human glioblastoma

por Abbott, Rebecca C, Verdon, Daniel J, Gracey, Fiona M, Hughes‐Parry, Hannah E, Iliopoulos, Melinda, Watson, Katherine A, Mulazzani, Matthias, Luong, Kylie, D’Arcy, Colleen, Sullivan, Lucy C, Kiefel, Ben R, Cross, Ryan S, Jenkins, Misty R
Publicado 2021

Novel high‐affinity EGFRvIII‐specific chimeric antigen receptor T cells effectively eliminate human glioblastoma

por Abbott, Rebecca C, Verdon, Daniel J, Gracey, Fiona M, Hughes‐Parry, Hannah E, Iliopoulos, Melinda, Watson, Katherine A, Mulazzani, Matthias, Luong, Kylie, D’Arcy, Colleen, Sullivan, Lucy C, Kiefel, Ben R, Cross, Ryan S, Jenkins, Misty R
Publicado 2021